Ronidazole Capsules - Product defect recall alert
Product defect recall alert for: Ronidazole Capsules by Nova Laboratories Ltd
We wish to make the veterinary surgeons aware that Nova Laboratories Ltd have initiated a Class II recall for all strengths of the unlicensed medicine, Ronidazole capsules as mentioned below:
| Batch No | Strength | Expiry date |
|---|---|---|
| SCP2MA365 | 80MG | 25-Jul-24 |
| SCP2MA732 | 50MG | 05-Aug-24 |
| SCP2MB491 | 100MG | 22-Aug-24 |
| SCP2MB604 | 85MG | 27-Aug-24 |
| SCP2N0843 | 20MG | 24-Oct-24 |
| SCP2N1963 | 50MG | 23-Nov-24 |
| SCP2N1845 | 100MG | 21-Nov-24 |
| SCP2N1844 | 50MG | 21-Nov-24 |
| SCP201964 | 100MG | 23-Nov-24 |
| SCP2N2114 | 10MG | 29-Nov-24 |
| SCP2N3214 | 100MG | 26-Dec-24 |
This is due to a recall by the manufacturer of the active pharmaceutical ingredient (API), Ronidazole, who have been instructed to recall 2 batches of the API during a competent authority inspection of their facility. This is due to the quality of the product not being guaranteed.
Nova Laboratories Ltd is contacting veterinary surgeons to examine inventory and quarantine products subject to this recall.
For further information regarding the recall, please contact Nova Customer Services department on 0116 223 0100.